PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. - Wikidata - awgldk - TriplyDB

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

http://www.wikidata.org/entity/Q34763274

about

Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer Potential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate Cancer Landmarks in prostate cancer diagnosis: the biomarkers Urinary biomarkers for prostate cancer Emerging critical role of molecular testing in diagnostic genitourinary pathology A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis.Current early diagnostic biomarkers of prostate cancer Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score.Novel diagnostic biomarkers for prostate cancer.Long noncoding RNAs as putative biomarkers for prostate cancer detection.Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer Can urinary PCA3 supplement PSA in the early detection of prostate cancer?A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer.Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.Temporal changes in the clinical approach to diagnosing prostate cancer Prostate cancer markers: An update.Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.Active surveillance for prostate cancer Biomarkers in prostate cancer surveillance and screening: past, present, and future.Markers for detection of prostate cancer.Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer Urine markers in monitoring for prostate cancer.MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.Biomarkers for prostate cancer detection.Role of histopathology and molecular markers in the active surveillance of prostate cancer.Formalized prediction of clinically significant prostate cancer: is it possible?Toward the detection of prostate cancer in urine: a critical analysis.Biomarkers for the diagnosis of new and recurrent prostate cancer.Molecular biomarkers in prostate cancer.PCA3 in the detection and management of early prostate cancer.Urinary biomarkers for prostate cancer: a review.

P2860

Q26767044-D7A10B0E-0F28-455D-9852-712D6181E028 Q26784517-99F6539C-8149-471B-833B-C18C8227BE61 Q26852523-15D985DF-76EC-4AFB-BD2C-47709871890A Q27009110-CECA7B2E-E9F0-4FE5-996A-FB9FCEA2B6FC Q27021371-41BB3F74-EFA8-46CA-8957-3774DC744980 Q27022638-0FA8E201-20CB-44BD-B8E3-C476FD76E581 Q30422070-2416EDF3-6DDA-4A56-9359-FD12C5E39133 Q33776728-749B2496-7C84-4CAB-B457-E494D02EDEDD Q33922390-88339598-C925-47FB-A492-588DD141FDC0 Q34127059-A26CAE0E-DB3F-4A08-B89A-48BEABEC3A0F Q34130249-FE2A737D-481E-4F59-9905-227EC7911EF6 Q34231678-B42F92EA-501F-4E81-B0A2-AA0A1647DE1B Q34409743-6BF8D850-0795-4282-93B7-A690AA6E6BE4 Q34602348-14A97874-0302-4C43-AE4A-E43AB841F003 Q34692263-FE8FBD28-89FE-441E-A81D-73B6F80F9CFD Q35022483-D5914618-507B-4ECD-8FA1-FCB6F8A3E5A9 Q35074229-264853C4-274B-4DAF-9971-6DDE27967FB0 Q35251546-4EB844BA-E649-4B1B-96B3-133DAD021958 Q35858216-09B5FA98-8E9F-45CE-AECD-54E0C30068B7 Q36025180-5439DC2E-E3DC-4E75-96FC-F61DD0F3CA46 Q36520528-502FA284-048C-4E75-9D7F-4056C77C4EBD Q36640109-1A968780-0C30-430E-A672-B58FAD47AD8B Q36730598-A172A15A-09B9-4965-B6E0-8FACC5D6F524 Q36907574-3FC42D83-0FB9-4FFE-9CA4-DD35BB09A788 Q36979944-C891ADF5-1B53-45D4-826B-9248274722EB Q37025434-AFF12DD0-750E-4D34-A547-40E65C85F495 Q37138594-6788B56B-E9DA-4C96-A7B8-C785D1FD32C9 Q37300931-315BE576-6A9C-49D1-88B7-3D80D9DA3E01 Q37328403-78FC072C-3248-498F-B816-7DB1DE860A39 Q37422990-647398AC-F28E-4A97-A59C-994FA1A7CC1F Q37571461-43B674F6-B366-4A3B-A7E2-AB0E7414467F Q37615759-6EEEF7D3-664C-419C-85AF-91FC2AFB1721 Q37656233-D1177EF6-9EAA-4968-B111-9BAEDFC64964 Q37878468-212F81E1-17DD-4F36-9C77-BAD5A73D9885 Q37988363-824EF74C-F67E-4A1E-BCC6-A6B80E1A96D5 Q38047103-1E1CA603-FA06-4FFB-8B65-DE0008372409 Q38052926-CCDB3FEF-FC22-4D4C-BD41-2E7256F71B1E Q38088854-8E7AD82C-D4B8-4E05-88E5-60063D14F277 Q38090552-CBA691A1-C630-4120-B80C-E225DA938413 Q38092578-7C87D9AD-6E44-4199-898D-5C65A388166C

P2860

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

http://www.wikidata.org/entity/Q34763274

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

PCA3 molecular urine assay cor ...... dates for active surveillance.

@ast

PCA3 molecular urine assay cor ...... dates for active surveillance.

@en

PCA3 molecular urine assay cor ...... dates for active surveillance.

@nl

type

label

PCA3 molecular urine assay cor ...... dates for active surveillance.

@ast

PCA3 molecular urine assay cor ...... dates for active surveillance.

@en

PCA3 molecular urine assay cor ...... dates for active surveillance.

@nl

prefLabel

PCA3 molecular urine assay cor ...... dates for active surveillance.

@ast

PCA3 molecular urine assay cor ...... dates for active surveillance.

@en

PCA3 molecular urine assay cor ...... dates for active surveillance.

@nl

P1433

Q34763274-BB1C09E6-7025-4DD9-9255-EEDD6B0E82B8

P1476

Q34763274-0D09DEA5-B085-47DC-8473-6D37CCE18744

P2093

Q34763274-0EDB53EC-5471-4041-BD7A-B5D98092914E

Q34763274-505E9540-7D77-4AB8-82E4-131DF22591CD

Q34763274-56A688DC-0BEE-414A-9AB7-34F48DC4735C

Q34763274-8480E32F-6E0E-4647-AF38-8DB28D188671

Q34763274-8E2AE4F7-5903-470B-9E64-846065ED53BB

Q34763274-D20ACE35-5E8F-4853-944D-01C7F9A4CE7E

Q34763274-DB67082E-5728-4CB3-ADE6-C4E5EF7BD121

Q34763274-DC1D50B9-FECD-4B65-B8EE-7E07D516ED82

Q34763274-EA52F804-6238-4386-8204-2B012CC43C77

Q34763274-FDB9A562-4669-42F5-B57C-4D82BC81AC05

P304

Q34763274-845B46C2-F779-467C-97EC-52E6897B38D4

P31

Q34763274-51B7A6E6-C85B-4349-8C13-5992B3C38248

P356

Q34763274-1ABE3097-DC13-4CC5-A08A-C657F8D2C808

P407

Q34763274-9BA82C1C-3C3C-4811-9C03-EB2A0BCFFA06

P433

Q34763274-FB74BABA-5448-4A74-9F97-22C99C1A7BB9

P478

Q34763274-500CA086-83C1-4D50-BD48-6028666575AD

P577

Q34763274-D61FCAB5-452B-43D8-8BE6-38B77FC3275A

P5875

Q34763274-BB3F28DE-80B2-40AC-8AC8-6E0E86494427

P698

Q34763274-13DDB887-92CF-47A8-A3BC-F3D1AE19287C

P356

J.JURO.2008.01.013

P1433

The Journal of Urology

P1476

PCA3 molecular urine assay cor ...... dates for active surveillance.

@en

P2093

Amy Blase

http://www.w3.org/2001/XMLSchema#string

Harry Rittenhouse

http://www.w3.org/2001/XMLSchema#string

Herbert A Fritsche

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Nakanishi

http://www.w3.org/2001/XMLSchema#string

Jack Groskopf

http://www.w3.org/2001/XMLSchema#string

John W Davis

http://www.w3.org/2001/XMLSchema#string

Patricia Troncoso

http://www.w3.org/2001/XMLSchema#string

R Joseph Babaian

http://www.w3.org/2001/XMLSchema#string

S Vikas Kumar

http://www.w3.org/2001/XMLSchema#string

Viju Bhadkamkar

http://www.w3.org/2001/XMLSchema#string

P304

1804-9; discussion 1809-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2008.01.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5499817

http://www.w3.org/2001/XMLSchema#string

P698

18353398

http://www.w3.org/2001/XMLSchema#string